Hoth Therapeutics deploys OpenClaw AI platform for drug discovery

Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing

Sanofi and Regeneron's Dupixent gains Japan approval as first targeted therapy for bullous pemphigoid

Rhythm Pharmaceuticals selects PANTHERx Rare as exclusive US distribution partner for IMCIVREE expanded indication

Bambusa Therapeutics names new CFO

Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform

Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China

Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004

Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial

Immunic granted European patent for vidofludimus calcium dosing regimens

Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment

Pfizer reports positive Phase 2 results for trispecific antibody in atopic dermatitis

Kelun-Biotech and Harbour BioMed receive China IND approval for atopic dermatitis therapy

Melodia Therapeutics reports award of US patent covering MLD-151

GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline